SLU-PP-332

SLU-PP-332 is a small molecule that acts as a pan-agonist of the estrogen-related receptors (ERRα, β, and γ), a family of nuclear receptors that regulate genes involved in mitochondrial biogenesis and oxidative metabolism. Because these pathways are also activated by endurance exercise, SLU-PP-332 is often described as an exercise-mimetic compound. By engaging ERR signaling, this compound is designed to support the cellular machinery involved in fat oxidation and aerobic energy production, independent of physical activity level. EdgeRx offers SLU-PP-332 as an emerging clinician-supervised option, prescribed per physician protocol for eligible patients within an individualized metabolic or performance-focused plan.